These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
560 related articles for article (PubMed ID: 21295685)
1. The connections between neural crest development and neuroblastoma. Jiang M; Stanke J; Lahti JM Curr Top Dev Biol; 2011; 94():77-127. PubMed ID: 21295685 [TBL] [Abstract][Full Text] [Related]
2. The embryonic trunk neural crest microenvironment regulates the plasticity and invasion of human neuroblastoma via TrkB signaling. Kasemeier-Kulesa JC; Spengler JA; Muolo CE; Morrison JA; Woolley TE; Schnell S; Kulesa PM Dev Biol; 2021 Dec; 480():78-90. PubMed ID: 34416224 [TBL] [Abstract][Full Text] [Related]
3. Linking neural crest development to neuroblastoma pathology. Gonzalez Malagon SG; Liu KJ Development; 2022 Aug; 149(15):. PubMed ID: 35905010 [TBL] [Abstract][Full Text] [Related]
4. Neural crest cells development and neuroblastoma progression: Role of Wnt signaling. Ahmad MH; Ghosh B; Rizvi MA; Ali M; Kaur L; Mondal AC J Cell Physiol; 2023 Feb; 238(2):306-328. PubMed ID: 36502519 [TBL] [Abstract][Full Text] [Related]
6. WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma. Becker J; Wilting J Cell Mol Life Sci; 2018 Mar; 75(6):1057-1070. PubMed ID: 29058015 [TBL] [Abstract][Full Text] [Related]
8. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Lovén J; Zinin N; Wahlström T; Müller I; Brodin P; Fredlund E; Ribacke U; Pivarcsi A; Påhlman S; Henriksson M Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1553-8. PubMed ID: 20080637 [TBL] [Abstract][Full Text] [Related]
9. Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma. Wylie LA; Hardwick LJ; Papkovskaia TD; Thiele CJ; Philpott A Dis Model Mech; 2015 May; 8(5):429-41. PubMed ID: 25786414 [TBL] [Abstract][Full Text] [Related]
10. Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. Arscott WT; LaBauve AE; May V; Wesley UV Oncogene; 2009 Jan; 28(4):479-91. PubMed ID: 18978811 [TBL] [Abstract][Full Text] [Related]
11. The quest to develop an effective therapy for neuroblastoma. Bhoopathi P; Mannangatti P; Emdad L; Das SK; Fisher PB J Cell Physiol; 2021 Nov; 236(11):7775-7791. PubMed ID: 33834508 [TBL] [Abstract][Full Text] [Related]
12. Cell death-based treatment of neuroblastoma. Valter K; Zhivotovsky B; Gogvadze V Cell Death Dis; 2018 Jan; 9(2):113. PubMed ID: 29371588 [TBL] [Abstract][Full Text] [Related]
13. Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer. Wulf AM; Moreno MM; Paka C; Rampasekova A; Liu KJ Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769149 [TBL] [Abstract][Full Text] [Related]
14. MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV. Wang J; Zhang X; Yao H; Le Y; Zhou W; Li J; Lu L; Chen M; Li X Hum Cell; 2020 Jan; 33(1):261-271. PubMed ID: 31894478 [TBL] [Abstract][Full Text] [Related]
15. A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations. Saldana-Guerrero IM; Montano-Gutierrez LF; Boswell K; Hafemeister C; Poon E; Shaw LE; Stavish D; Lea RA; Wernig-Zorc S; Bozsaky E; Fetahu IS; Zoescher P; Pötschger U; Bernkopf M; Wenninger-Weinzierl A; Sturtzel C; Souilhol C; Tarelli S; Shoeb MR; Bozatzi P; Rados M; Guarini M; Buri MC; Weninger W; Putz EM; Huang M; Ladenstein R; Andrews PW; Barbaric I; Cresswell GD; Bryant HE; Distel M; Chesler L; Taschner-Mandl S; Farlik M; Tsakiridis A; Halbritter F Nat Commun; 2024 May; 15(1):3745. PubMed ID: 38702304 [TBL] [Abstract][Full Text] [Related]
16. CFC1 is a cancer stemness-regulating factor in neuroblastoma. Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the developmental origin of neuroblastoma: an overview. Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192 [TBL] [Abstract][Full Text] [Related]
18. Environmental cues from neural crest derivatives act as metastatic triggers in an embryonic neuroblastoma model. Ben Amar D; Thoinet K; Villalard B; Imbaud O; Costechareyre C; Jarrosson L; Reynaud F; Novion Ducassou J; Couté Y; Brunet JF; Combaret V; Corradini N; Delloye-Bourgeois C; Castellani V Nat Commun; 2022 May; 13(1):2549. PubMed ID: 35538114 [TBL] [Abstract][Full Text] [Related]
19. RNA N Cheng J; Xu L; Deng L; Xue L; Meng Q; Wei F; Wang J Sci Rep; 2020 Aug; 10(1):13624. PubMed ID: 32788584 [TBL] [Abstract][Full Text] [Related]
20. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells. Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]